Stockreport

SAB BIO to Participate in Upcoming Investor Conferences

SAB Biotherapeutics, Inc.  (SABS) 
PDF MIAMI, Jan. 31, 2025 (GLOBE NEWSWIRE) -- SAB BIO (Nasdaq: SABS), (“SAB BIO” or the “Company”), a clinical-stage biopharmaceutical company with a novel immunotherapy pl [Read more]